HB0159 creates a new article in Wyoming law regulating chemical abortions and the handling of abortion drugs and related waste. It requires a health care provider to physically examine the patient, be physically present when the first abortion drug is taken, schedule a follow-up visit within seven days, and provide a catch kit and medical waste bag with disposal instructions. A provider who knowingly violates these requirements commits a felony punishable by up to three years in prison, a fine of up to $10,000, or both. The bill also defines key terms such as “chemical abortion,” “abortion drug,” and “unborn baby,” and includes exceptions for the pregnant woman herself and for treatment of ectopic pregnancy.
The bill also adds environmental restrictions aimed at abortion drugs. It prohibits abortion drugs from entering wastewater, public water systems, or waters of the state, and places responsibility on manufacturers for disposal, mitigation, and remediation of environmental effects. If abortion-drug-related chemicals are found in water systems, manufacturers would face strict, joint, and several liability, with damages apportioned among manufacturers if the specific source cannot be identified. The bill authorizes civil actions, sets a six-year limitations period, restricts certain defenses, and directs the Department of Environmental Quality and Department of Health to adopt rules to implement the act. It also amends existing statutes concerning disposal of aborted fetal remains and environmental regulation.
HB0159 would significantly expand state regulation of medication abortion and create new enforcement mechanisms tied to both medical practice and environmental law. It would impose new duties on providers, create criminal penalties, and expose manufacturers of abortion drugs to broad civil liability for alleged contamination or disposal-related impacts. The bill also contains extensive provisions on immunity, venue, choice of law, severability, and limits on injunctive relief, indicating an intent to make the law difficult to block or narrow through litigation.
The general sentiment reflected in the available voting history appears favorable in committee, with the House Labor Committee recommending do pass by a 6-2 vote. No transcript excerpts are available, so there is no recorded discussion to show detailed arguments, but the committee result suggests majority support among members present. The bill’s sponsors and co-sponsors indicate strong backing from a bloc of legislators aligned with abortion restrictions.
The main points of contention are likely to be the bill’s abortion restrictions, the criminal penalties for providers, and the novel environmental-liability framework for drug manufacturers. Opponents would likely object to the physical-presence requirement, the mandatory follow-up and disposal obligations, and the attempt to assign liability for abortion-drug traces in water systems. Supporters appear to frame the measure as protecting public health, unborn life, and water quality, while critics would likely view it as an aggressive expansion of abortion regulation and litigation exposure.
HB0159 would create a new statutory framework in Title 35 governing chemical abortions, including provider conduct requirements, criminal penalties, and civil liability for abortion-drug manufacturers. It would also amend existing Wyoming law on disposal of aborted fetal remains and environmental regulation, and require rulemaking by the Department of Health and the Environmental Quality Council. The bill would affect health care providers, abortion-drug manufacturers, patients seeking medication abortion, and state agencies responsible for health and environmental oversight.
The limited voting history suggests the bill had majority support in the House Labor Committee, which recommended it do pass by a 6-2 vote. With no transcript excerpts available, there is no direct record of debate, but the sponsor list and committee vote indicate that the bill is backed by legislators favoring tighter abortion regulation. The available context suggests the measure is politically supported by its proponents, while likely opposed by members concerned about abortion access, medical practice restrictions, and environmental-liability expansion.
The most notable controversy is the bill’s attempt to regulate medication abortion through both medical and environmental law. Critics would likely focus on the requirement that a provider be physically present when the first abortion drug is taken, the felony penalty for noncompliance, and the mandate to provide disposal kits and follow-up care. Another major point of contention is the bill’s strict liability scheme for manufacturers if abortion-drug chemicals are detected in water systems, including apportionment among all manufacturers when the source cannot be identified. The bill’s broad immunity, venue, and anti-injunction provisions also suggest an effort to limit judicial review, which is likely to draw legal and constitutional objections.